KAIST and Checkmate Capital Complete Investment in Bredis Healthcare
May 25, 2023 18:00 ET
|
Checkmate Capital
Investment Accelerates Bredis’ Capacity Expansion, Integrated Platform Development and Commercialization in Korea Further Announcement of Bredis’ Agreements with Major University Hospitals SEOUL,...
Checkmate Capital Group Announces Opening of New Flagship Office in Seoul, Korea
March 12, 2023 18:00 ET
|
Checkmate Capital
SEOUL, Korea and PASADENA, Calif., March 12, 2023 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce the opening of its flagship corporate offices in Seoul, Korea...
Precision Livestock Technologies Closes Preferred Equity Financing
September 07, 2022 11:00 ET
|
Checkmate Capital
Capital to Support Commercialization and Ongoing R&D Engages Checkmate Capital Group as Strategic Advisor PASADENA, Calif. and DALLAS, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Precision Livestock...
Checkmate Capital Group and KAIST Venture Investment Holdings Announce Partnership & Selection as TIPS Operator
June 26, 2022 23:12 ET
|
Checkmate Capital
LOS ANGELES and SEOUL, South Korea, June 26, 2022 (GLOBE NEWSWIRE) -- A consortium formed by KAIST Venture Investment Holdings and Checkmate Capital Group has been selected as a program operator for...
UPDATE - KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital therapeutics and electroceuticals
June 21, 2022 00:41 ET
|
Checkmate Capital
KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital therapeutics and electroceuticalsLeading the domestic Korean digital therapeutics (DTx) market through...
KT Corporation and Hanmi Pharmaceutical promote business cooperation with Digital Pharm, a Korean company specializing in digital treatment devices and electronic drugs
June 20, 2022 20:36 ET
|
Checkmate Capital
KT and Hanmi Pharmaceutical to jointly invest in Digital Pharm, a company specializing in digital treatment devices and electronic drugsLeading the domestic Korean digital therapeutics (DTx) market...
Checkmate Capital Group Completes Seed Investment in Lactiga, Inc.
November 02, 2020 10:00 ET
|
Checkmate Capital
PRINCETON, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Lactiga, Inc. (“Lactiga”), an award-winning biotherapeutics company developing anti-infective biologics, is pleased to announce the completion of...
NeuroSigma Receives Bridge Financing from Checkmate Capital
September 21, 2020 11:00 ET
|
Checkmate Capital
To Support Targeted Commercialization and Global Partnering of FDA-Approved Non-Drug Treatment for Pediatric ADHD LOS ANGELES, Sept. 21, 2020 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. (“NeuroSigma”),...
Monarch Biosciences Closes Seed Round Financing
April 06, 2020 12:00 ET
|
Checkmate Capital
Led by Checkmate Capital Group Development of Biomaterial-based Neurovascular Stent and Platform for Local Delivery of Cell Therapies LOS ANGELES, April 06, 2020 (GLOBE NEWSWIRE) -- Monarch...
Checkmate Capital Group Announces Opening of New Corporate Office in Pasadena, California
March 16, 2020 18:32 ET
|
Checkmate Capital
LOS ANGELES, March 16, 2020 (GLOBE NEWSWIRE) -- Checkmate Capital Group, LLC (“Checkmate”) is pleased to announce that it is moving its corporate headquarters to new offices in Pasadena,...